SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarrs Group Regulatory News (CARR)

  • There is currently no data for CARR

Carr's Group (CARR): Optimising value for shareholders

9 Feb 2022 07:00

Edison Investment Research Limited Carr's Group (CARR): Optimising value for shareholders 09-Feb-2022 / 07:00 GMT/BST


 

London, UK, 9 February 2022

 

Carr's Group (CARR): Optimising value for shareholders

Over several decades Carr's Group has diversified both within and outside the UK agricultural market. This has reduced the group's exposure to the vagaries of the British climate, farming policy and volatile commodity prices and taken it into activities that generate substantially higher margins and present opportunities for stronger growth than the traditional agriculture sector in individual countries. However, while the board sees potential for growth in each of the three divisions, there are limited opportunities to exploit inter-divisional synergies, so it has announced a strategic review.

 

Our DCF analysis gives an indicative value of 170p/share (unchanged). Given the ongoing strategic review, a sum-of-the-parts (SOTP) analysis is more appropriate as this recognises that stocks engaged purely in engineering activities or providing speciality agricultural inputs command substantially higher multiples than those involved in supplying commoditised agricultural inputs. Our SOTP calculation gives a value of 292.7p/share, suggesting that any potential strategic activity that released the value of individual divisions by splitting up the group would be beneficial for shareholders.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Anne Margaret Crow +44 (0)20 3077 5700 industrials@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1277981 09-Feb-2022 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
13th Oct 20257:00 amRNS-RCompletion of Name Change
10th Oct 202512:08 pmRNSDirector/PDMR Shareholding
25th Sep 20255:57 pmRNSChange of Name
23rd Sep 20257:00 amRNSTrading update and Name change
8th Sep 20254:22 pmRNSDirector/PDMR Shareholding
2nd Sep 20254:53 pmRNSTotal Voting Rights
28th Aug 20257:00 amRNS-RUpdate on NZ Strategic Distribution Partnership
21st Aug 20259:23 amRNSDirector/PDMR Shareholding
19th Aug 202510:40 amRNSDirector/PDMR Shareholding
11th Aug 202510:07 amRNSDirector/PDMR Shareholding
5th Aug 202511:49 amRNSTotal Voting Rights
23rd Jul 20253:09 pmRNSHolding(s) in Company
23rd Jul 202512:35 pmRNSDirector/PDMR Shareholding
23rd Jul 202512:33 pmRNSDirector/PDMR Shareholding
18th Jul 20253:32 pmRNSDirector/PDMR Shareholding
18th Jul 20258:48 amRNS-RCarr’s Group enters partnership with Vétalis
10th Jul 202510:15 amRNSBlock Listing Six Monthly Return
10th Jul 202510:13 amRNSBlock Listing Six Monthly Return
10th Jul 202510:11 amRNSBlock Listing Six Monthly Return
8th Jul 20251:08 pmRNSDirector/PDMR Shareholding
8th Jul 20251:06 pmRNSDirector/PDMR Shareholding
8th Jul 20251:05 pmRNSDirector/PDMR Shareholding
4th Jul 202511:49 amRNSHolding(s) in Company
1st Jul 202510:01 amRNSHolding(s) in Company
1st Jul 20257:00 amRNSConfirmation of CEO appointment
25th Jun 20258:01 amRNSHolding(s) in Company
20th Jun 20257:00 amRNSResults of Tender Offer
18th Jun 202512:22 pmRNSResults of General Meeting
17th Jun 202510:08 amRNSTotal Voting Rights
30th May 20254:36 pmRNSTotal Voting Rights
21st May 20257:00 amRNSProposed Tender Offer
19th May 202511:47 amRNSTotal Voting Rights
9th May 20253:36 pmRNSDirector/PDMR Shareholding
7th May 20257:00 amRNSInterim Results and CEO Succession
29th Apr 20253:34 pmRNSTotal Voting Rights
22nd Apr 20253:26 pmRNSSale of Engineering Division and Notice of Results
11th Mar 20253:00 pmRNSDirector/PDMR Shareholding
6th Mar 202510:04 amRNSBlocklisting Application
14th Feb 20251:56 pmRNSResult of AGM
14th Feb 202511:41 amRNSTR-1
31st Jan 20255:16 pmRNSHolding(s) in Company
30th Jan 20255:45 pmRNSDirectors' Remuneration Report - Correction
23rd Jan 20254:16 pmRNSDirector/PDMR Shareholding
23rd Jan 20254:15 pmRNSDirector/PDMR Shareholdings
17th Jan 20251:21 pmRNSHolding(s) in Company
16th Jan 20257:00 amRNSSale of Engineering Division for £75m
31st Dec 20248:59 amRNSBlock Listing six monthly return
31st Dec 20248:56 amRNSBlock Listing six monthly return
30th Dec 202410:35 amRNSTotal Voting Rights
24th Dec 20247:00 amRNSNotice of AGM and Publication of ARA for FY24

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.